Remission Rates In Childhood Acute Myeloid Leukemia (AML) Utilizing a Dose-Intensive Induction Regimen with or without Gemtuzumab Ozogamicin (GO): Initial Results From the Children's Oncology Group Phase III Trial, AAML0531
| Autor: | Gamis, Alan S, Alonzo, Todd A, Gerbing, Robert B *, Aplenc, Richard, Sung, Lillian, Meshinchi, Soheil, Raimondi, Susana C., Hirsch, Betsy A. *, Kahwash, Samir *, Heerema-McKenney, Amy *, Winter, Laura *, Glick, Kathleen *, Byron, Patti *, Burden, Laura *, Wallas, Tanya *, Davies, Stella M., Smith, Franklin O. |
|---|---|
| Zdroj: | In Blood 19 November 2010 116(21):182-182 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|